Module Database Search



MODULE DESCRIPTOR
Module Title
Advanced Pharmacy Practice
Reference PHM039 Version 2
Created September 2017 SCQF Level SCQF 11
Approved October 2014 SCQF Points 60
Amended September 2017 ECTS Points 30

Aims of Module
To enable the development of relevant knowledge, skills, attitudes and competencies required for effective advanced pharmacy practice.

Learning Outcomes for Module
On completion of this module, students are expected to be able to:
1 Evidence the ability to be an adaptable and innovative advanced practitioner capable of developing new knowledge and skills to advance own practice and that of others.
2 Evidence self-direction and originality in tackling and solving problems, and act autonomously and as part of a team in planning and implementing strategies for professional developments.
3 Take accountability for decisions on complex patient related issues in the absence of complete data.
4 Critically analyse published literature, health policy and current service provision using the principles of needs assessment to make evidence based recommendations for the development, implementation and evaluation of pharmacy led services.
5 Demonstrate highly developed professional communication skills and be able to show an ability to clearly articulate complex concepts to specialist and non-specialist audiences.

Indicative Module Content
Theoretical approaches to effective adult and lifelong learning. Effective approaches to teaching, learning and assessment in healthcare practice. Mentoring and facilitating the development of others in healthcare practice. Local and national policies relating to education and training of healthcare professionals. Aspects of management and leadership including needs assessment in the context of direct patient care services in an advanced are of practice. The planning, delivery and evaluation of services that encompass pharmaceutical care planning, medication review and comprehensive evaluation of evidence relating to the therapeutics for individual patients. Critical evaluation of literature. Research and evaluation protocols. Research and evaluation methodologies. Research governance.

Module Delivery
Online distance learning by problem based study materials including directed reading and contact / structured discussion with peers and academic and e-tutor staff.

Indicative Student Workload Full Time Part Time
Contact Hours N/A N/A
Non-Contact Hours N/A 600
Placement/Work-Based Learning Experience [Notional] Hours N/A N/A
TOTAL N/A 600
Actual Placement hours for professional, statutory or regulatory body    

ASSESSMENT PLAN
If a major/minor model is used and box is ticked, % weightings below are indicative only.
Component 1
Type: Coursework Weighting: 0% Outcomes Assessed: 1, 2, 3
Description: A range of written ssignments each linked to core topics within the module and the collation of a portfolio of evidence including linked reflective summaries. This will be assessed on a Pass/Fail basis.
Component 2
Type: Coursework Weighting: 50% Outcomes Assessed: 4
Description: Generation of a proposal for the development, implementation and evaluation of a pharmacist led service. This contributes 50% towards the final Module grade.
Component 3
Type: Examination Weighting: 50% Outcomes Assessed: 5
Description: Viva voce examination and defence of portfolio. This contributes 50% towards the final module grade.

MODULE PERFORMANCE DESCRIPTOR
Explanatory Text
To pass this module, the student must achieve a module Grade of Grade D or better.
Module Grade Minimum Requirements to achieve Module Grade:
A When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 70% or more and C1 is passed. A minimum of 40% is required in each of C2 and C3. All required pieces of evidence must be present in the portfolio.
B When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 60-69% and C1 is passed. A minimum of 40% is required in each of C2 and C3. All required pieces of evidence must be present in the portfolio.
C When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 50-59% and C1 is passed. A minimum of 40% is required in each of C2 and C3. All required pieces of evidence must be present in the portfolio.
D When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 40-49% and C1 is passed. A minimum of 40% is required in each of C2 and C3. All required pieces of evidence must be present in the portfolio.
E When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 35-39% and C1 is passed. Some pieces of required evidence are not present in the portfolio.
F When the marks (expressed as percentage) obtained for the equally weighted assessments C2 and C3 give a final aggregate mark of 35% or less; Less than 40% in either C2 or C3; AND/OR C1 is not passed.
NS Non-submission of work by published deadline or non-attendance for examination

Module Requirements
Prerequisites for Module An undergraduate degree in pharmacy from a UK university or overseas equivalent, at a minimum of honours level and one years post-registration experience OR an integrated masters degree in pharmacy (MPharm) and profressional registration OR in consultation with the Course Leader.
Corequisites for module None.
Precluded Modules None.

INDICATIVE BIBLIOGRAPHY
None.

 

Robert Gordon University, Garthdee House, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781